Jennifer Burstein

Insider Reports History

Entity
Individual
Location
C/O Loxo Oncology, Inc., One Landmark Square, Suite 1122, Stamford, CT
Signature
/s/ Jonathan Allan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Burstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Stoke Therapeutics, Inc. Director Director Stock Option (Right to Buy) 7.64K Jun 5, 2024 Direct

Insider Reports Filed by Jennifer Burstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STOK Stoke Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
STOK Stoke Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
STOK Stoke Therapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 8, 2022 Director
STOK Stoke Therapeutics, Inc. Jun 8, 2021 1 $0 4 Jun 25, 2021 Director